MedRhythms Announces an Expansion of Intellectual Property Portfolio, Securing Patent on Audio Engine for Digital Therapeutics Platform

PORTLAND, MaineApril 17, 2020 /PRNewswire/ — MedRhythms, a Portland, Maine-based company building direct stimulation digital therapeutics that use sensors, software, and music to measure and improve walking, announced today the issuance of patent US20190022351A1 by the United States Patent and Trademark Office (USPTO).

This is the second granted patent in MedRhythms’ portfolio. The patent, entitled “Enhancing Music for Repetitive Motion Activities,” covers the audio engine enabling MedRhythms’ digital therapeutics platform. Read more

Related Posts

UMaine professor McGill receives top German research award

ORONO — University of Maine ecology professor Brian McGill was awarded the Humboldt Research Award, one of the most prestigious scientific...

20 July 2023

Four Maine workforce programs could get $6.5M in fed funding

Four workforce training programs in Maine could receive nearly $6.5 million in federal funding through the markup of the fiscal year 2024 financial...

18 July 2023

Music as medicine: FDA approves stroke damage therapy from Portland startup

Doctors may soon start writing an unconventional prescription to help stroke survivors regain their ability to walk: music. MedRhythms, a Portland...

14 July 2023